NCT00751387

Brief Summary

The study is a cross sectional, epidemiology study of disease severity for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in four geographic regions in Australia (Illawarra, Sutherland, Hunter Urban and Hunter Rural).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
559

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2008

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 12, 2008

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2008

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

November 30, 2010

Status Verified

November 1, 2010

Enrollment Period

10 months

First QC Date

September 11, 2008

Last Update Submit

November 27, 2010

Conditions

Ankylosing SpondylitisPsoriatic ArthritisRheumatoid Arthritis

Outcome Measures

Primary Outcomes (1)

  • Proportion of rheumatoid arthritis/psoriatic arthritis/ankylosing spondylitis patients in defined disease severity categories

    Single visit

Secondary Outcomes (1)

  • Proportion of patients exposed to biological disease modifying antirheumatic drugs

    Single visit

Study Arms (1)

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary care

You may qualify if:

  • Adult patients with a diagnosis of rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis who have visited a primary care centre within one of the specified catchment areas for their condition within the last 24 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Unknown Facility

Georgetown, 2298, Australia

Location

Unknown Facility

Miranda, 2228, Australia

Location

Unknown Facility

Newcastle, 2300, Australia

Location

Unknown Facility

Wollongong, 2500, Australia

Location

MeSH Terms

Conditions

Spondylitis, AnkylosingArthritis, PsoriaticArthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Axial SpondyloarthritisSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritisPsoriasisSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesRheumatic DiseasesConnective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Medical Monitor

    Wyeth is now a wholly owned subsidiary of Pfizer

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 11, 2008

First Posted

September 12, 2008

Study Start

November 1, 2008

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

November 30, 2010

Record last verified: 2010-11

Locations

AU(4)